title: Additional indications for interferon therapy: basal cell carcinoma, carcinoid, and chronic active hepatitis.
authors.affiliation: Clinical Research Division, Schering Corporation, Kenilworth, NJ 07033.
authors.forename: R J
authors.initials: RJ
authors.lastname: Spiegel
mesh_terms: D002276:Carcinoid Tumor / Q000628:therapy*; D002280:Basal Cell Carcinoma / Q000628:therapy*; D006521:Hepatitis, Chronic / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects / Q000627:therapeutic use*; D007414:Intestinal Neoplasms / Q000628:therapy; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000628:therapy
chemical_list: D007370:Interferon Type I; D011994:Recombinant Proteins